Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SL606P is designated as a "pseudogene," which means it is a nonfunctional segment of DNA that closely resembles the sequence of a functional 7SL RNA gene[6]. The functional 7SL RNA is a structural and regulatory RNA component of the signal recognition particle (SRP), crucial for SRP-mediated targeting of secretory and membrane proteins in eukaryotic cells[1][3]. In contrast, the RN7SL606P locus does not encode a functional RNA product or protein and shows hallmarks of a processed pseudogene: most pseudogenes arise by mechanisms such as retrotransposition, leading to loss of regulatory elements and/or truncation[5][6]. The many 7SL pseudogenes in the human genome are thought to be evolutionary remnants generated by reverse transcription of the parental gene's RNA, followed by random insertion into the genome[5][6]. The parent 7SL gene gives rise to the functional RNA component of the signal recognition particle, a ribonucleoprotein complex responsible for protein translocation into the endoplasmic reticulum and, indirectly, secretory pathway trafficking[1][3]. Unlike its functional counterpart, RN7SL606P contains sequence defects (such as truncations or loss of regulatory elements) and is not known to be transcribed or to have a physiological function[5][6]. Pseudogenes as a class may have regulatory effects through various mechanisms, such as acting as competing endogenous RNAs, generating regulatory noncoding RNAs, or modulating parental gene expression by antisense interactions[6]. However, for RN7SL606P specifically, no such function has been reported. Key points: - RN7SL606P is not a protein, enzyme, transporter, or receptor, and is not considered a therapeutic target[5][6]. - It does not have associated interacting drugs or mechanisms of action, nor is it used as a biomarker or associated with therapeutic safety concerns[6]. - The designation as a pseudogene indicates it likely arose by duplication or retrotransposition of the 7SL parental gene followed by functional decay[5][6]. - Its presence in the genome is of evolutionary and genetic interest, mainly serving as a nonfunctional residual sequence[5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 606, pseudogene (RN7SL606P).